| Experiences with metoprolol Durules, a slow-release formulation in hypertension. | |
| | |
MedLine Citation:
|
PMID: 7358203 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The antihypertensive effect and the tolerability of metoprolol Durules have been studied in fifty-five patients with mild to moderate hypertension. The patients' diastolic blood pressure was greater than or equal to 95 mm Hg in order to qualify for entry. Thirty-seven out of fifty-three patients completing the study (70%) were treated with metoprolol Durules monotherapy throughout the study. The mean blood pressure was reduced from 153/101 to 138/92 mm Hg after metoprolol Durules compared to placebo (p less than 0.001). Twenty-seven patients received one Durules daily and ten patients received two Durules daily as the final dose. Of the sixteen patients not responding on metoprolol Durules, six patients achieved satisfactory control, i.e. a diastolic blood pressure below 95 mm Hg, when given 200 mg metoprolol + 25 mg hydrochlorothiazide (HCT). The results indicate that most patients with mild or moderate hypertension can be controlled with metoprolol Durules monotherapy given one daily. The addition of HCT gives a significant benefit in moderate hypertension, where metoprolol monotherapy is not sufficient. |
| | |
Authors:
|
J Tuomilehto; A Nissinen |
Related Documents
:
|
1712273 - Cilazapril in congestive heart failure. a pilot study. 3989133 - Important differences between short- and long-term hemodynamic effects of amiodarone in... 2365413 - Platelet ionic calcium and serum total calcium in essential hypertension. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of international medical research Volume: 8 ISSN: 0300-0605 ISO Abbreviation: J. Int. Med. Res. Publication Date: 1980 |
Date Detail:
|
Created Date: 1980-05-23 Completed Date: 1980-05-23 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0346411 Medline TA: J Int Med Res Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 44-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Pressure / drug effects Delayed-Action Preparations Drug Therapy, Combination Female Heart Rate / drug effects Humans Hydrochlorothiazide / therapeutic use Hypertension / drug therapy* Male Metoprolol / administration & dosage, adverse effects, blood, therapeutic use* Middle Aged Propanolamines / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Delayed-Action Preparations; 0/Propanolamines; 37350-58-6/Metoprolol; 58-93-5/Hydrochlorothiazide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of essential hypertension with a combination of propranolol and bendrofluazide.
Next Document: Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.